AGFA Gevaert NV
XMUN:AGE

Watchlist Manager
AGFA Gevaert NV Logo
AGFA Gevaert NV
XMUN:AGE
Watchlist
Price: 0.4345 EUR -0.23%
Market Cap: €200.8m

AGFA Gevaert NV
Investor Relations

AGFA Gevaert makes imaging and printing products and software. Its business is split between healthcare and printing. In healthcare, it sells digital radiology systems, image management software, and related services that help hospitals and clinics capture, store, and review medical images. In printing, it sells offset printing plates, chemicals, and workflow systems that help commercial printers prepare and produce printed materials. Its customers are mainly hospitals, imaging centers, and medical networks on one side, and commercial printers and packaging-related print shops on the other. The company makes money by selling equipment, software licenses, consumables, and service contracts. That mix matters because many customers buy the core system first and then keep buying plates, chemicals, upgrades, support, and software over time. AGFA Gevaert sits in a niche part of the imaging chain. It is not a general consumer electronics company; it focuses on specialized tools for capturing, managing, and reproducing images in medical and industrial settings. This gives it a business model tied to recurring consumable sales and long-term customer relationships, especially where image quality, reliability, and workflow integration are important.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 12, 2026
AI Summary
Q1 2026

Top line: Agfa said Q1 was a solid quarter, with comparable sales growth of 1.7% helped by higher silver prices, strong Digital Printing Systems growth, and a better mix in Imaging and Chemicals.

Profitability: Adjusted EBITDA rose by EUR 10 million year on year, mainly from savings, tighter cost control, and the ability to pass higher silver costs through to customers.

Cash flow: Free cash flow was minus EUR 42 million in Q1, but management said that without the silver impact it would have been around breakeven.

HealthCare IT: The cloud transition is still on track, but order intake was soft in Q1 and management expects a much stronger Q2 because several deals are already signed.

Outlook: The group confirmed its full-year outlook overall, but the mix changed: Imaging and Chemicals looks better than previously expected, while Green Hydrogen has become softer in 2026.

Green Hydrogen: Agfa now expects 2026 to be a trough year for ZIRFON, with a rebound in 2027 as more European projects reach final investment decision.

Key Financials
Comparable sales growth
1.7%
Adjusted EBITDA
EUR 10 million increase
Annualized savings
EUR 57 million
Free cash flow
minus EUR 42 million
Silver cash impact
more than EUR 40 million
Recurring revenue share
67%
HealthCare IT order intake growth
high single digits
HealthCare IT recurring revenue
5%
Industrial Solutions top-line growth
10%
Net debt
EUR 58 million
Revolving credit facility draw
EUR 129 million
Liquidity headroom
EUR 120 million
Leverage
1.1
Interest cover
12.5
EBITDA headroom
EUR 51.6 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Pascal Juery
President, CEO, President of Radiology Solutions & Director
No Bio Available
Ms. Fiona Lam
Chief Financial Officer
No Bio Available
Mr. Wilfried Van Lishout
Compliance Officer & Company Secretary
No Bio Available
Ms. Viviane Dictus
Director of Corporate Communications
No Bio Available
Mr. Gunther Koch
Chief Human Resources Officer & Head of Sustainability
No Bio Available
Mr. Vincent Wille
President of Digital Print & Chemicals
No Bio Available
Ms. Nathalie McCaughley
President of HealthCare IT
No Bio Available
Mr. Jeroen Spruyt
President of Agfa's Radiology Solutions Division
No Bio Available

Contacts

Address
ANTWERPEN
Mortsel
Septestraat 27
Contacts
+3234442111.0
www.agfa.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett